cCD79a expression in a case of plasma cell leukemia.


In the present report we analyzed the immunophenotype of the neoplastic cells in a case of primary plasma cell leukemia (PCL). We performed simultaneous analysis of bone marrow and peripheral blood samples to investigate minor phenotypic variations that could explain the tendency of a population to leave medullary compartments. No major differences were observed between the two populations. The phenotype of the malignant clone was: CD38+, CD138+, CD19-, CD56+, CD117-, CD33+, CD44 , CD49e , cCD79a+ with positive cytoplasmic stain for kappa and IgG. Our findings expands the potential uses of cCD79a to cases of PCL with atypical morphology.

Cite this paper

@article{Alonso1998cCD79aEI, title={cCD79a expression in a case of plasma cell leukemia.}, author={Mar{\'i}a Luisa Alonso and Enriqueta Rubiol and R Mateu and Camino Estivill and Mar Bellido and Judith Balma{\~n}{\`a} and J F Nomded{\'e}u}, journal={Leukemia research}, year={1998}, volume={22 7}, pages={649-53} }